Identification of genes involved in resistance to interferon-α in cutaneous T-cell lymphoma

American Journal of Pathology

Volumn 161, Issue 5, 2002, Pages 1825-1837

  Tracey, Lorraine ^a   Villuendas, Raquel ^a   Ortiz, Pablo ^b   Dopazo, Ana ^a   Spiteri, Inmaculada ^a   Lombardia, Luis ^a   Rodríguez Peralto, Jose L ^b,c   Fernández Herrera, Jesús ^c   Hernández, Almudena ^c   Fraga, Javier ^b,c   Dominguez, Orlando ^a   Herrero, Javier ^a   Alonso, Miguel A ^c   Dopazo, Joaquin ^a   Piris, Miguel A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CELL CYCLE PROTEIN; COMPLEMENTARY DNA; GENE PRODUCT; PROTEIN MAL; PSORALEN; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL INCLUSION; CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; CYTOKINE PRODUCTION; DNA MICROARRAY; DRUG RESPONSE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPAIN; TIME; TRANSCRIPTION REGULATION;

EID: 0036840235     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64459-8     Document Type: Article

References (42)

1. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD: How cells respond to interferons. Annu Rev Biochem 1998, 67:227-264
2. Platanias LC: Interferons: Laboratory to clinic investigations. Curr Opin Oncol 1995, 7:560-565
3. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O: Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 1994, 19:222-227
4. Darnell JR JE, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421
5. Sangfelt O, Erickson S, Castro J, Heiden T, Einhorn S, Grander D: Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines. Cell Growth Differ 1997, 8:343-352
6. Xu D, Erickson S, Szeps M, Gruber A, Sangfelt O, Einhorn S, Pisa P, Grander D: Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells. Blood 2000, 96:4313-4318
7. Jewell AP, Worman CP, Lydyard PM, Yong KL, Giles FJ, Goldstone AH: Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br J Haematol 1994, 88:268-274
8. Matikainen S, Sareneva T, Ronni T, Lehtonen A, Koskinen PJ, Julkunen I: Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood 1999, 93:1980-1991
9. Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grander D: Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Oncogene 1999, 18:2798-2810
10. Abramovich C, Shulman LM, Ratovitski E, Harroch S, Tovey M, Eld P, Revel M: Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta. EMBO J 1994, 13:5871-5877
11. McKendry R, John J, Flavell D, Muller M, Kerr IM, Stark GR: High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc Natl Acad Sci USA 1991, 88:11455-11459
12. Sakamoto H, Yasukawa H, Masuhara M, Tanimura S, Sasaki A, Yuge K, Ohtsubo M, Ohtsuka A, Fujita T, Ohta T, Furukawa Y, Iwase S, Yamada H, Yoshimura A: A Janus kinase inhibitor. JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 1998, 92:1668-1676
13. Sun WH, Pabon C, Alsayed Y, Huang PP, Jandeska S, Uddin S, Platanias LC, Rosen ST: Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood 1998, 91:570-576
14. Yang CH, Murti A, Pfeffer LM: STAT3 complements defects in an interferon-resistant cell line: Evidence for an essential role for STAT3 in interferon signaling and biological activities. Proc Natl Acad Sci USA 1998, 95:5568-5572
15. Siegel RS, Pandolfino T, Guitart J, Rosen S, Kuzel TM: Primary cutaneous T-cell lymphoma: Review and current concepts. J Clin Oncol 2000, 18:2908-2925
16. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science 1997, 276:1268-1272
17. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM: Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996, 14:457-460
18. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson Jr J, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO: The transcriptional program in the response of human fibroblasts to serum. Science 1999, 283:83-87
19. Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative PCR. Genome Res 1996, 6:986-994
20. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH: Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA 1990, 87:1663-1667
21. Eberwine J: Amplification of mRNA populations using aRNA generated from immobilized oligo(dT)-T7 primed cDNA. Biotechniques 1996, 20:584-591
22. Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, Hughes JE, Snesrud E, Lee N, Quackenbush J: A concise guide to cDNA microarray analysis. Biotechniques 2000, 29:548-556
23. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D: GeneCards: A novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics 1998, 14:656-664
24. Copie-Bergman C, Gaulard P, Maouche-Chretien L, Briere J, Haioun C, Alonso MA, Romeo PH, Leroy K: The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood 1999, 94:3567-3575
25. Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, Guccion JG: Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood 1980, 55:409-417
26. Alonso MA, Millan J: The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J Cell Sci 2001, 114:3957-3965
27. Ndubuisi MI, Guo GG, Fried VA, Etlinger JD, Sehgal PB: Cellular physiology of STAT3: Where's the cytoplasmic monomer? J Biol Chem 1999, 274:25499-25509
28. Takaoka A, Mitani Y, Suemori H, Sato M, Yokochi T, Noguchi S, Tanaka N, Taniguchi T: Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science 2000, 288:2357-2360
29. Millan J, Puertollano R, Fan L, Alonso MA: Caveolin and MAL, two protein components of internal detergent-insoluble membranes, are in distinct lipid microenvironments in MDCK cells. Biochem Biophys Res Commun 1997, 233:707-712
30. Zamorano J, Wang HY, Wang R, Shi Y, Longmore GD, Keegan AD: Regulation of cell growth by IL-2: Role of STAT5 in protection from apoptosis but not in cell cycle progression. J Immunol 1998, 160:3502-3512
31. Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder E, Buckler AJ, Wise C, Ashley J, Lovett M, Valentine MB, Look AT, Gerald W, Housman DE, Haber DA: Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1998, 95:13765-13770
32. Sumegi J, Huang D, Lanyi A, Davis JD, Seemayer TA, Maeda A, Klein G, Seri M, Wakiguchi H, Purtilo DT, Gross TG: Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood 2000, 96:3118-3125
33. Sumazaki R, Kanegane H, Osaki M, Fukushima T, Tsuchida M, Matsukura H, Shinozaki K, Kimura H, Matsui A, Miyawaki T: SH2D1A mutations in Japanese males with severe Epstein-Barr virus-associated illnesses. Blood 2001, 98:1268-1270
34. Nagahori T, Dohi M, Matsumoto K, Saitoh K, Honda ZI, Nakamura T, Yamamoto K: Interferon-gamma upregulates the c-Met/hepatocyte growth factor receptor expression in alveolar epithelial cells. Am J Respir Cell Mol Biol 1999, 21:490-497
35. Goodwin RG, Alderson MR, Smith CA, Armitage RJ, VandenBos T, Jerzy R, Tough TW, Schoenborn MA, Davis-Smith T, Hennen K: Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 1993, 73:447-456
36. Gravestein LA, Amsen D, Boes M, Calvo CR, Kruisbeek AM, Borst J: The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. Eur J Immunol 1998, 28:2208-2216
37. Prasad KV, Ao Z, Yoon Y, Wu MX, Rizk M, Jacquot S, Schlossman SF: CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA 1997, 94:6346-6351
38. Stephanou A, Isenberg DA, Nakajima K, Latchman DS: Signal transducer and activator of transcription-1 and heat shock factor-1 interact and activate the transcription of the Hsp-70 and Hsp-90beta gene promoters. J Biol Chem 1999, 274:1723-1728
39. Gerner C, Frohwein U, Gotzmann J, Bayer E, Gelbmann D, Bursch W, Schulte-Hermann R: The Fas-induced apoptosis analysed by high throughput proteome analysis. J Biol Chem 2000, 275:39018-39026
40. Amati B, Alevizopoulos K, Vlach J: Myc and the cell cycle. Front Biosci 1998, 3:D250-D268
41. Bossone SA, Asselin C, Patel AJ, Marcu KB: MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc Natl Acad Sci USA 1992, 89:7452-7456
42. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995, 81:495-504